Company: NDRA
Filing Date: 2025-11-26
Form Type: 424B4
Source: 0001213900-25-115097
Chunk: 40

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-26
Form: 424B4
Chunk 40
---
(c), 14 or 15(d) of the Exchange Act, prior to the termination of this offering, including
all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the
registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference
into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents.

We will provide to each person,
including any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the information that has been incorporated
by reference in this prospectus but not delivered with this prospectus. Exhibits to the filings will not be sent, however, unless those
exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus supplement. You may request
a copy of this information at no cost, by writing or telephoning us at the following address or telephone number:

<div align='center'>ENDRA Life Sciences Inc.

3600 Green Court, Suite 350

Ann Arbor, Michigan 48105

Telephone: (734) 335-0468

22

ENDRA LIFE SCIENCES INC.

Up to 2,677,680 Shares of Common Stock

PROSPECTUS

November 26, 2025</div>